53.07
0.72%
0.37
Dopo l'orario di chiusura:
51.05
-2.02
-3.81%
Precedente Chiudi:
$52.70
Aprire:
$52.77
Volume 24 ore:
2.49M
Relative Volume:
0.98
Capitalizzazione di mercato:
$9.87B
Reddito:
$2.69B
Utile/perdita netta:
$-214.04M
Rapporto P/E:
-33.47
EPS:
-1.5857
Flusso di cassa netto:
$98.43M
1 W Prestazione:
+4.22%
1M Prestazione:
-23.60%
6M Prestazione:
-0.82%
1 anno Prestazione:
-18.51%
Exact Sciences Corp Stock (EXAS) Company Profile
Nome
Exact Sciences Corp
Settore
Industria
Telefono
608-284-5700
Indirizzo
5505 ENDEAVOR LANE, MADISON, WI
Confronta EXAS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
EXAS | 53.07 | 9.87B | 2.69B | -214.04M | 98.43M | -1.5857 |
TMO | 516.10 | 196.16B | 42.37B | 6.14B | 7.78B | 15.26 |
DHR | 235.09 | 167.14B | 23.74B | 3.89B | 4.98B | 7.93 |
A | 132.05 | 37.71B | 6.50B | 1.41B | 1.42B | 3.82 |
IQV | 197.53 | 35.48B | 15.32B | 1.41B | 1.96B | 5.95 |
IDXX | 418.55 | 33.75B | 3.84B | 866.24M | 792.60M | 9.80 |
Exact Sciences Corp Stock (EXAS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-08-28 | Iniziato | Wells Fargo | Overweight |
2024-06-27 | Iniziato | Scotiabank | Sector Outperform |
2024-06-03 | Ripresa | Jefferies | Buy |
2024-01-02 | Aggiornamento | The Benchmark Company | Hold → Buy |
2023-12-14 | Iniziato | Guggenheim | Buy |
2023-12-13 | Iniziato | Wolfe Research | Outperform |
2023-10-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2023-09-28 | Iniziato | Bernstein | Outperform |
2023-08-02 | Downgrade | The Benchmark Company | Buy → Hold |
2023-05-10 | Aggiornamento | Craig Hallum | Hold → Buy |
2023-05-05 | Iniziato | UBS | Neutral |
2023-03-09 | Aggiornamento | Citigroup | Neutral → Buy |
2023-02-10 | Downgrade | Credit Suisse | Outperform → Neutral |
2023-01-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
2022-10-19 | Downgrade | Craig Hallum | Buy → Hold |
2022-08-25 | Iniziato | Credit Suisse | Outperform |
2022-06-03 | Iniziato | Piper Sandler | Neutral |
2021-11-03 | Downgrade | Raymond James | Strong Buy → Outperform |
2021-07-29 | Reiterato | BTIG Research | Buy |
2021-07-29 | Reiterato | Canaccord Genuity | Buy |
2021-07-29 | Reiterato | Oppenheimer | Outperform |
2021-07-29 | Reiterato | Stifel | Buy |
2021-06-15 | Iniziato | Raymond James | Strong Buy |
2021-06-03 | Iniziato | Goldman | Buy |
2021-05-25 | Iniziato | Wells Fargo | Equal Weight |
2021-01-28 | Iniziato | Truist | Buy |
2020-10-29 | Downgrade | UBS | Buy → Neutral |
2020-10-28 | Downgrade | Citigroup | Buy → Neutral |
2020-10-08 | Ripresa | BTIG Research | Buy |
2020-04-02 | Iniziato | Evercore ISI | Outperform |
2020-01-10 | Ripresa | BTIG Research | Buy |
2020-01-07 | Iniziato | Citigroup | Buy |
2019-12-13 | Iniziato | Dougherty & Company | Buy |
2019-11-15 | Iniziato | Stifel | Buy |
2019-10-17 | Reiterato | BofA/Merrill | Buy |
2019-10-01 | Ripresa | Craig Hallum | Buy |
2019-09-26 | Iniziato | Oppenheimer | Outperform |
2019-02-26 | Aggiornamento | Goldman | Neutral → Buy |
2018-10-09 | Iniziato | UBS | Buy |
2018-09-05 | Ripresa | The Benchmark Company | Hold |
2018-08-13 | Reiterato | Canaccord Genuity | Buy |
2018-04-03 | Aggiornamento | BTIG Research | Neutral → Buy |
2018-01-29 | Iniziato | Goldman | Neutral |
2018-01-08 | Reiterato | The Benchmark Company | Buy |
2017-11-13 | Downgrade | Robert W. Baird | Outperform → Neutral |
2017-11-01 | Downgrade | BTIG Research | Buy → Neutral |
Mostra tutto
Exact Sciences Corp Borsa (EXAS) Ultime notizie
Swiss National Bank Increases Holdings in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Madison-based Exact Sciences reports Q3 results short of analysts’ expectations - Chippewa Herald
EULAV Asset Management Has $20.78 Million Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now - Insider Monkey
Exact Sciences Co. (NASDAQ:EXAS) Sees Large Drop in Short Interest - MarketBeat
Exact Sciences Co. (NASDAQ:EXAS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Exact Sciences Partners with Actor and TV Personality Carlos Ponce to Increase Awareness of Colon Cancer Screening Among Hispanic Community - Business Wire
EXAS Stock Set to Benefit From Favorable Study Data Backing MCED Test - Yahoo Finance
Chairman of The Board & CEO of Exact Sciences Picks Up 2.7% More Stock - Yahoo Finance
Exact Sciences Co. (NASDAQ:EXAS) Shares Acquired by Simplify Asset Management Inc. - MarketBeat
Exact Sciences showcases early cancer detection test data at AACR meeting - Clinical Trials Arena
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy - BioSpace
Capital World Investors Reduces Stake in Exact Sciences Corp - GuruFocus.com
Exact Sciences CEO Kevin Conroy buys $1 million in stock By Investing.com - Investing.com Nigeria
Exact Sciences reports progress in early cancer detection - Investing.com
Exact Sciences reports progress in early cancer detection By Investing.com - Investing.com UK
Exact Sciences CEO Kevin Conroy buys $1 million in stock - Investing.com India
Exact Sciences' Cancer Test Shows 28% Better Early Detection, Could Cut Deaths by 17% | EXAS Stock News - StockTitan
Los Angeles Capital Management LLC Takes Position in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Corp (EXAS) Stock Price Down 6.11% on Nov 12 - GuruFocus.com
Exact Sciences Co. (NASDAQ:EXAS) Shares Purchased by WCM Investment Management LLC - MarketBeat
Exact Sciences Corporation (EXAS) Rebounded from the Previous Quarter - Yahoo Finance
15,260 Shares in Exact Sciences Co. (NASDAQ:EXAS) Acquired by Lisanti Capital Growth LLC - MarketBeat
Exact Sciences: Cancer Detection Stalwart's Bad Quarter Resets Its Overgrown Market Cap. - Seeking Alpha
Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Principal Financial Group Inc. - MarketBeat
Wellington Management Group LLP Reduces Stake in Exact Sciences Corp - GuruFocus.com
ARK Investment Management LLC Sells 117,043 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Analysts Set Expectations for Exact Sciences Q4 Earnings - MarketBeat
Exact Sciences’ forecast cut shocks analysts - Yahoo Finance
Exact Sciences Corporation (NASDAQ:EXAS) Q3 2024 Earnings Call Transcript - Insider Monkey
Van ECK Associates Corp Sells 17,484 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat
Exact Sciences Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance
Exact Sciences: Q3 Sell-Off May Be Unjustified But Long-Term Outlook A Concern (EXAS) - Seeking Alpha
Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount - Yahoo Finance
Piper Sandler maintains Overweight rating on Exact Sciences shares - Investing.com
Exact Sciences stock target cut by Benchmark, retains Buy rating - Investing.com
Exact Sciences (NASDAQ:EXAS) Shares Gap Down on Disappointing Earnings - MarketBeat
Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point - Yahoo Finance
Exact Sciences (NASDAQ:EXAS) Given New $65.00 Price Target at Benchmark - MarketBeat
Craig Hallum Issues Pessimistic Forecast for Exact Sciences (NASDAQ:EXAS) Stock Price - MarketBeat
Exact Sciences Stock Down On Q3 Earnings & Revenue Miss, '24 View Cut - Barchart
Exact Sciences (NASDAQ:EXAS) Price Target Lowered to $67.00 at Robert W. Baird - MarketBeat
Exact Sciences stock target cut, outperform rating on revenue outlook - Investing.com
Exact Sciences Stock Down on Q3 Earnings & Revenue Miss, '24 View Cut - Yahoo Finance
Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken? - Yahoo! Voices
Exact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com
Exact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight - GuruFocus.com
Exact Sciences Reports Strong Q3 Performance and Pipeline Advances - TipRanks
Exact Sciences Announces Third-Quarter 2024 Results - BioSpace
Exact Sciences Corp Azioni (EXAS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):